TELIF (Telescope Innovations) Tariff Resilience Score: 5/10 (As of Jul. 05, 2026)


TELIF Telescope Innovations Corp TELIF
27 GF Score
Price $0.51
GF Value $0.39
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Telescope Innovations Tariff Resilience Score?

Telescope Innovations TELIF -0.21% 27 Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus rates TELIF with a GF Score™ of 27/100 and a GF Value™ of $0.39 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 1,369 Biotechnology companies, Telescope Innovations ranks better than 62.38% on this metric.

Telescope Innovations has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Telescope Innovations has Telescope Innovations, involved in tech development, faces moderate tariff exposure on imported components. Its innovative focus and potential for strategic partnerships offer some mitigation.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Telescope Innovations might have Average Resilient.

Telescope Innovations  (OTCPK:TELIF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Telescope Innovations Tariff Resilience Score Related Terms

TELIF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Telescope Innovations's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telescope Innovations Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telescope Innovations's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Telescope Innovations's Tariff Resilience Score falls into.


TELIF
27GF Score
Telescope Innovations Corp TELIF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Telescope Innovations (TELIF) has a Tariff Resilience Score of 5 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Telescope Innovations ranks #515 out of 1369 companies in the Biotechnology industry, placing it in the top 37.6%.
Is Telescope Innovations' Tariff Resilience Score too high?
Telescope Innovations' current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Telescope Innovations' value of 5 is 25% above this industry median. Based on the distribution chart, Telescope Innovations ranks #515 out of 1369 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Telescope Innovations has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Telescope Innovations ranks #515 out of 1369 companies for Tariff Resilience Score. This puts Telescope Innovations in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Telescope Innovations' value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,369 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telescope Innovations's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telescope Innovations's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.39, compared to a current price of $0.51 — trading 30.5% above its estimated fair value. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Telescope Innovations' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telescope Innovations (TELIF) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of $0.51 is trading 30.5% above its estimated GF Value™ of $0.39. GuruFocus considers Telescope Innovations to be Significantly Overvalued.

Key valuation signals for TELIF:

  • Tariff Resilience Score: 5
  • GF Value™: $0.39 vs. price of $0.51 (30.5% above fair value)
  • GF Score™: 27/100 with 1 warning sign
  • Industry Position: 25% above the Biotechnology median (#515 of 1369)

No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telescope Innovations Business Description

Other Exchanges J4U:GermanyTELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
27GF Score

Get the complete analysis for TELIF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$0.39
GF Value